Clinical Trial
Treatment of perennial rhinitis with 2% solution of sodium cromoglycate
- PMID: 817384
Item in Clipboard
Clinical Trial
Treatment of perennial rhinitis with 2% solution of sodium cromoglycate
Rhinology.
1975 Aug.
Abstract
This trial has demonstrated that S.C.G. is significantly better than placebo and therefore that a 2% solution of S.C.G. is effective in the treatment of perennial rhinitis. It would appear that better results can be obtained in patients who have a demonstrable allergic aetiology with a nasal eosinophilia.
Similar articles
-
Perennial rhinitis - its causation and treatment, a trial of a new formulation of sodium cromoglycate.Rhinology. 1978 Sep;16(3):139-47. Rhinology. 1978. PMID: 103182 Clinical Trial.
-
Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis.Ann Allergy. 1982 Sep;49(3):131-4. Ann Allergy. 1982. PMID: 6126145 Clinical Trial.
-
Treatment of chronic perennial allergic rhinitis: a double-blind trial of cromolyn sodium.Ann Allergy. 1977 Sep;39(3):169-74. Ann Allergy. 1977. PMID: 409315 Clinical Trial.
-
Sodium cromoglycate (cromolyn sodium). II. Allergic rhinitis and other conditions.Drugs. 1974;7(3):283-96. doi: 10.2165/00003495-197407030-00003. Drugs. 1974. PMID: 4153068 Review. No abstract available.
-
The effect of cromolyn on nasal disease.Ear Nose Throat J. 1986 Oct;65(10):449-56. Ear Nose Throat J. 1986. PMID: 3096687 Review. No abstract available.